简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2019-10-30 15:23 The Valence Group Advises SK Capital on Acquisition of PP&S Division From PolyOne
2019-10-30 09:28 Boehringer Ingelheim Advances First Pan-KRAS Inhibitor BI 1701963 into Clinical Testing
2019-10-29 18:30 Terns Pharmaceuticals Receives Fast Track Designation From the FDA for TERN-101, an FXR Agonist for the Treatment of NASH
2019-10-25 09:43 Global Health Progress Launched to Drive Cross-sectoral Collaborations in Support of the Sustainable Development Goals (SDGs)
2019-10-24 18:47 Velodyne Announces ADAS Collaboration with Hyundai Mobis
2019-10-24 13:42 Committed to Patients in China – Groundbreaking Ceremony for Cook China Campus
2019-10-24 12:04 Covetrus Announces CEO and Chairman Transition
2019-10-23 16:32 Takeda Acquires License for First-In-Class Celiac Disease Therapy from COUR Pharmaceuticals Following Positive Phase 2a Proof-of-Concept Study
2019-10-23 10:05 Nordson EFD Introduces New 797PCP Progressive Cavity Pump Systems for Continuous Volumetric Dispensing
2019-10-22 14:53 ResMed Introduces AirFit N30, World’s First Tube-Down Nasal Cradle CPAP Mask
2019-10-22 12:03 New Research Reveals Updated Patient Preferences on Digital Health Technology
2019-10-21 14:15 Concept Medical is Granted CE Certification for Their Sirolimus Coated MagicTouch Group of Products
2019-10-21 13:27 Retrospective Real-World Comparative Analysis Highlights Safety of Vedolizumab and Anti-TNFα Therapies in Biologic-Naïve Patients with Ulcerative Colitis or Crohn’s Disease
2019-10-17 15:29 Johns Hopkins Center for Health Security, World Economic Forum and Bill & Melinda Gates Foundation Host Pandemic Exercise and Livestream
2019-10-17 11:44 Accomplishments of Dr. Steven Rosenberg in Cancer Immunotherapy Inspire Young Researchers in Japan & XIV Fujio Cup Quiz on Stem Cells Is Won by India.
2019-10-17 09:37 Boehringer Ingelheim Announces First Patient Enrolled in Phase II Trial of Novel Cystic Fibrosis Treatment (BALANCE-CFTM 1)
2019-10-15 18:17 Terns Pharmaceuticals to Present Positive Preclinical Data on FXR Agonist TERN-101 at The Liver Meeting® 2019
2019-10-15 15:18 Takeda Agrees to Divest Select OTC and Non-core Assets to Acino for Over $200 Million USD
2019-10-15 09:27 MPIC Raises Php 35.3bn from KKR’s Investment in Hospital Unit
2019-10-15 09:14 Analysis of Patients With Prior Gastrectomy Treated With LONSURF® (trifluridine/tipiracil) Published in JAMA Oncology

Business Wire Weibo

Press Releases

Latest Releases